Although these findings suggest a promising therapeutic use for H4R antagonists in the modulation of chronic lung diseases, the biochemical basis underlying the protective and beneficial effects of these drugs are unknown and need to be further elucidated. This evidence concerns the gene HRH4 and chronic lung disease.